Indacaterol/ glycopyrronium/ mometasone (Enerzair breezhaler)
- Status:
- Grey - after consultant/specialist initiation
- Decision Date:
- August 2021
Comments
GREY after specialist initiation: to be used in severe asthma with a demonstrated airflow obstruction
Grey Drug Classifications
- 8. Exceptionality where a small cohort of patients may benefit from prescribing can be identified
search again